Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    Lu-31-130
Show Display Options
Rank Status Study
1 Completed Efficacy of Lu 31-130 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Zicronapine;   Drug: Placebo
2 Completed Efficacy of Lu 31-130 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Zicronapine;   Drug: Olanzapine
3 Completed Safety and Efficacy of Zicronapine in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Zicronapine;   Drug: Risperidone
4 Completed
Has Results
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Zicronapine open-label lead-in 10 mg daily;   Drug: Zicronapine 10 mg daily;   Drug: Zicronapine 20 mg once weekly;   Drug: Zicronapine 30 mg once weekly;   Drug: Zicronapine 45 mg once weekly

Indicates status has not been verified in more than two years